Randomized, Double-blind Study to Assess the Efficacy and Safety of α-lipoic Acid Versus BK-C-0701 in Subjects With Diabetic Neuropathy

Summary

The purpose of this study is to determine the: Primary end point * change of Total symptom score Secondary end point * neurological test

Timeline

Start

2010-08

Primary completion

2012-04

Completion

—

Drugs

Indications